Wolverine Trading, LLC Vanda Pharmaceuticals Inc. Call Options Transaction History

Wolverine Trading, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$4.61 - $6.34 $305,182 - $419,708	-66,200 Reduced 81.53%	15,000 $70,000
Q2 2024 Aug 14, 2024	BUY	$3.91 - $6.5 $317,492 - $527,800	81,200 New	81,200 $458,000
Q3 2021 Nov 12, 2021	SELL	$15.35 - $21.27 $165,780 - $229,716	-10,800 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$15.71 - $21.51 $169,668 - $232,308	10,800 New	10,800 $220,000
Q3 2019 Nov 14, 2019	SELL	$12.27 - $15.79 $195,093 - $251,061	-15,900 Closed	0 $0
Q2 2019 Aug 20, 2019	SELL	$13.37 - $18.85 $189,854 - $267,670	-14,200 Reduced 47.18%	15,900 $224,000
Q1 2019 May 15, 2019	SELL	$17.59 - $31.05 $43,975 - $77,625	-2,500 Reduced 7.67%	30,100 $554,000
Q4 2018 Feb 14, 2019	BUY	$18.97 - $31.47 $343,357 - $569,607	18,100 Added 124.83%	32,600 $837,000
Q3 2018 Nov 14, 2018	SELL	$18.25 - $23.0 $9,125 - $11,500	-500 Reduced 3.33%	14,500 $333,000
Q1 2018 May 15, 2018	BUY	$14.05 - $20.2 $210,750 - $303,000	15,000 New	15,000 $253,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $282M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.